/

RX.V

BIOSYENT INC.Closed

15.89−0.08 −0.50%CAD

TSXV · as of Oct 14, 15:59 ET

Open

15.97

Prev close

15.97

Day range

15.4515.97

52-week range

10.6517.50

Volume

9.60K0.88×

Mkt cap

178.48M

P/E ttm

18.69

Fwd P/E

28.38

EPS ttm

0.8500

Div yield

1.38%

Earnings

Aug 20, 2026

From 52w high

−9.20%

Price Chart

Yahoo Finance · delayed

RX.VOct 14, 2026O 15.97H 15.97L 15.45C 15.89−0.08 (−0.50%)Vol 9.60K

SMA 5015.88
SMA 20014.70

1Y change +37.58% since Oct 10, 2025 close540 bars loadedTimes in America/TorontoDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

RX.V BIOSYENT INC. · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −5.98%
1 month: +0.25%
3 months: +8.84%
6 months: +6.64%
Year to date: +24.82%
1 year: +39.39%

Valuation & ownership

Market cap: 178.48M
Enterprise value: 173.90M
P/E (ttm): 18.69
Forward P/E: 28.38
PEG ratio: —
Price / book: 3.93
Price / sales (ttm): 3.21
EV / EBITDA: 11.68
EPS (ttm): 0.8500
EPS (forward): 0.5600
Beta (5y monthly): 0.59
Dividend yield: 1.38%
Payout ratio: 24.59%
Shares outstanding: 11.23M
Float: 9.14M
Short % of float: —
Short ratio (days): 0.21
Held by insiders: 34.95%
Held by institutions: 4.18%
Avg volume (3m): 10.91K
50-day average: 15.85
200-day average: 14.69
52-week change: +39.39%
S&P 500 52-week: +17.00%

Technicals (daily)

RSI (14): 43.8
vs 50-day SMA: +0.08%
vs 200-day SMA: +8.08%
50 / 200-day trend: ▲ 50 above 200
MACD vs signal: ▼ below
ATR (14) % of price: 3.23%
Realised vol (20d, ann.): 50.5%
From 52-week high: −9.20%
From 52-week low: +49.20%

ANR

Analyst Consensus

1 analysts

Consensus

—

Mean target

18.00

+13.28% implied

Low 18.00Median 18.00High 18.00

Recommendation trend

Now1 / 0 / 0

Buy / hold / sell counts

Financial Snapshot

Full statements →trailing twelve months

DES

About BIOSYENT INC.

Yahoo Finance profile

BioSyent Inc., together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia. It offers Tibella, a hormone replacement therapy consisting of tibolone; Inofolic, a natural health product to address polycystic ovarian syndrome symptoms; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by aging, menopause, stress, and chemotherapy; and Gelclair, a gel formulated to aid the pain or oral mucositis. In addition, the company provides Cathejell, a lubricant with anesthetic with the indication of lubricating and opening the urethra before the insertion of the catheter; and Proktis-M, a rectal suppository for the healing of the anus and rectum. The company sells its products through wholesalers and retail pharmacy chains. BioSyent Inc. was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006. The company was incorporated in 2006 and is headquartered in Mississauga, Canada.

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Headquarters: Mississauga, ON, Canada
Website: biosyent.com
Officers: Mr. René C. Goehrum Chairman, CEO & President
Mr. Robert J. March

SEAS

Seasonality · RX.V

2007–2026 · monthly returns

Strongest month Feb +14.93%Weakest month Jan −8.69%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	-1.0	25.3	-8.7	1.2	-4.4	3.9	1.7	8.4	4.4	-4.9			+24.8%
2025	0.0	1.8	-0.4	-2.2	8.3	0.0	-4.2	6.7	-4.4	-4.7	10.4	4.9	+15.7%
2024	-7.8	1.2	1.2	-1.1	5.2	10.5	2.0	6.4	-1.3	0.9	4.2	-2.3	+19.3%
2023	4.3	-0.7	3.4	1.3	-3.9	2.6	-0.4	7.2	-2.2	0.4	8.3	8.5	+31.7%
2022	-3.5	2.3	11.5	1.2	-11.4	-4.3	2.6	1.3	-4.3	-11.0	4.3	-2.8	−15.3%
2021	-6.7	0.3	1.4	4.0	-1.2	8.9	-7.7	-3.2	-5.3	-2.0	20.7	-1.7	+4.4%
2020	-5.1	-11.9	-29.2	13.0	16.4	5.3	21.4	15.3	0.0	0.0	-1.0	14.1	+29.7%
2019	-0.7	6.3	-10.7	-2.5	2.3	-16.0	0.8	-8.0	1.7	0.0	12.0	-9.2	−24.3%
2018	0.0	-5.7	9.8	1.8	-4.2	-3.6	3.2	-0.5	0.0	-2.8	-19.5	7.3	−16.0%
2017	-12.5	2.9	6.9	1.0	3.3	2.2	4.4	5.9	1.4	15.0	-3.3	-6.3	+20.0%
2016	-4.0	-1.9	7.0	-1.6	5.2	6.2	14.3	-9.7	3.8	2.4	-7.9	2.2	+14.3%
2015	-10.2	0.8	-15.4	-9.9	-9.6	-2.0	-5.4	0.6	-1.7	2.0	-0.1	0.0	−41.8%
2014	-20.7	40.2	12.9	-0.4	28.5	10.1	5.0	14.6	20.6	-0.5	-2.8	13.5	+182.4%
2013	9.8	27.7	3.1	-15.0	15.9	3.1	17.0	46.2	-0.4	47.0	11.8	12.7	+363.0%
2012	2.4	34.9	0.0	-8.6	11.3	5.1	35.5	47.6	-21.0	2.0	-7.0	-1.1	+119.0%
2011	-7.1	-15.4	-36.4	28.6	44.4	-30.8	66.7	73.3	7.7	10.7	77.4	-23.6	+200.0%
2010	0.0	16.7	0.0	14.3	-12.5	-28.6	0.0	0.0	80.0	-33.3	33.3	75.0	+133.3%
2009	-60.0	50.0	0.0	0.0	33.3	0.0	50.0	0.0	50.0	-11.1	-12.5	-14.3	+20.0%
2008	-22.2	114.3	-13.3	-38.5	37.5	-9.1	-10.0	-22.2	-14.3	-50.0	100.0	-16.7	−44.4%
2007	-21.1	20.0	-11.1	-6.2	6.7	-6.2	-6.7	-21.4	9.1	16.7	-14.3	-25.0	−52.6%

INSD

Insider Activity · RX.V

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

0 shares

Sells, 6 months

— shares

Net shares

Net change in insider shares

—

Date	Insider	Transaction	Shares	Value
Sep 30, 2026	Elford (Sara)Director of Issuer	Exercise of rights at price 11.60 per share.	345	$4.00K
Sep 30, 2026	Lockhard (Peter Douglas)Director of Issuer	—	1.5K	—
Sep 30, 2026	Lockhard (Peter Douglas)Director of Issuer	Exercise of rights at price 11.60 per share.	747	$8.67K
Sep 28, 2026	Biosyent Inc.Issuer	—	76.5K	—
Sep 21, 2026	Ashrafi (Seyed Ahmad)Director of Issuer	Disposition in the public market at price 11.52 per share.	700	$8.06K
Sep 21, 2026	Ashrafi (Seyed Ahmad)Director of Issuer	Disposition in the public market at price 11.63 per share.	1K	$11.63K
Sep 21, 2026	Ashrafi (Seyed Ahmad)Director of Issuer	Disposition in the public market at price 11.77 per share.	2.9K	$34.13K
Sep 21, 2026	Ashrafi (Seyed Ahmad)Director of Issuer	Disposition in the public market at price 11.91 per share.	1K	$11.91K
Sep 20, 2026	Ashrafi (Seyed Ahmad)Director of Issuer	Disposition in the public market at price 11.44 per share.	300	$3.43K
Sep 15, 2026	Biosyent Inc.Issuer	Redemption, retraction, cancelation, repurchase at price 11.22 per share.	75K	$841.80K
Sep 14, 2026	Ashrafi (Seyed Ahmad)Director of Issuer	Disposition in the public market at price 11.39 per share.	1.5K	$17.09K
Sep 13, 2026	Biosyent Inc.Issuer	Redemption, retraction, cancelation, repurchase at price 11.26 per share.	900	$10.13K
Sep 10, 2026	Biosyent Inc.Issuer	Redemption, retraction, cancelation, repurchase at price 11.28 per share.	600	$6.77K
Sep 10, 2026	Ashrafi (Seyed Ahmad)Director of Issuer	Disposition in the public market at price 11.31 per share.	200	$2.26K
Sep 10, 2026	Ashrafi (Seyed Ahmad)Director of Issuer	Disposition in the public market at price 11.28 per share.	1.3K	$14.67K
Sep 9, 2026	Ashrafi (Seyed Ahmad)Director of Issuer	Disposition in the public market at price 11.32 per share.	1K	$11.32K
Sep 2, 2026	Ashrafi (Seyed Ahmad)Director of Issuer	Disposition in the public market at price 11.60 per share.	700	$8.12K
Sep 1, 2026	Ashrafi (Seyed Ahmad)Director of Issuer	Disposition in the public market at price 11.56 per share.	100	$1.16K
Aug 30, 2026	Biosyent Inc.Issuer	—	10.4K	—
Aug 27, 2026	Wilton (Stephen Edwin William)Director of Issuer	Exercise of options at price 5.29 per share.	1.2K	$6.59K

RX.V

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

RX.V

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About BIOSYENT INC.

Seasonality · RX.V

Insider Activity · RX.V

Congress Trades · RX.V

Investors Holding RX.V

Investors Holding RX.V

Congress Trades · RX.V

Insider Activity · RX.V

Seasonality · RX.V

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About BIOSYENT INC.

Earnings & Dividends

News